Premium
Fulminant bilateral cerebral infarction caused by paradoxical embolism in a patient with protein S Ala525Val substitution
Author(s) -
Yoshikawa Yoji,
Kitayama Jiro,
Ishikawa Hiromi,
Nakamura Asako,
Taniguchi Fumina,
Morishita Eriko,
Ago Tetsuro,
Nakane Hiroshi,
Kitazono Takanari
Publication year - 2015
Publication title -
neurology and clinical neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
0ISSN - 2049-4173
DOI - 10.1111/ncn3.156
Subject(s) - medicine , cerebral infarction , cardiology , thrombus , patent foramen ovale , infarction , thrombophilia , protein c deficiency , thrombosis , venous thrombosis , ischemia , myocardial infarction , migraine
We report a 42‐year‐old woman who developed sudden fulminant cerebral infarction in the bilateral middle cerebral artery territories, causing status epilepticus and a decreased level of consciousness. Investigation showed thrombus in the right soleus vein and a patent foramen ovale, but no obvious embolic source, such as atrial fibrillation or a carotid or cerebral artery atherosclerotic lesion. Blood coagulation tests showed decreased levels of free protein S (25%) and total protein S (52%), and decreased protein S activity (15%). The patient was diagnosed with cerebral infarction as a result of paradoxical embolism, and type I protein S deficiency. DNA sequencing identified a novel point mutation in the PROS 1 gene, leading to the amino acid substitution, Ala525Val. It should be noted that this protein S mutation can cause thrombophilia and cerebral infarction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom